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α-Synucleinα-Synuclein, an intrinsically-disordered protein associated with Parkinson's disease, interacts with mito-
chondria, but the details of this interaction are unknown. We probed the interaction of α-synuclein and its
A30P variant with lipid vesicles by using ﬂuorescence anisotropy and 19F nuclear magnetic resonance. Both
proteins interact strongly with large unilamellar vesicles whose composition is similar to that of the inner mi-
tochondrial membrane, which contains cardiolipin. However, the proteins have no afﬁnity for vesicles mim-
icking the outer mitochondrial membrane, which lacks cardiolipin. The 19F data show that the interaction
involves α-synuclein's N-terminal region. These data indicate that the middle of the N-terminal region,
which contains the KAKEGVVAAAE repeats, is involved in binding, probably via electrostatic interactions be-
tween the lysines and cardiolipin. We also found that the strength of α-synuclein binding depends on the na-
ture of the cardiolipin acyl side chains. Eliminating one double bond increases afﬁnity, while complete
saturation dramatically decreases afﬁnity. Increasing the temperature increases the binding of wild-type,
but not the A30P variant. The data are interpreted in terms of the properties of the protein, cardiolipin demix-
ing within the vesicles upon binding of α-synuclein, and packing density. The results advance our under-
standing of α-synuclein's interaction with mitochondrial membranes.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Parkinson's disease and other neurodegenerative disorders are
characterized by cytoplasmic neuronal inclusions known as Lewy
bodies [1–4]. α-Synuclein, a 140-amino acid intrinsically disordered
protein, is the main component of Lewy bodies [5–8]. The protein
(Fig. 1A) comprises a positively-charged N-terminal region (residues
1–60) with an imperfect consensus repeat KTKEGV, a hydrophobic
middle segment known as the NAC region (Non Amyloid Component,
residues 61–95), and a negatively-charged C-terminal region (residues
96–140) [9,10].
α-Synuclein's exact functions remain obscure, but recentworkhigh-
lights its roles in neurotransmitter release, mitochondrial dysfunction,
and aging. One function involves SNARE-complex assembly at presyn-
aptic vesicles via its C-terminal regionwhile its N-terminal region is an-
chored to the vesicle [11]. The protein is important for synaptic activity
when the nerve terminals repeatedly release neurotransmitters, which
requires the assembly and disassembly of the complex.
α-Synuclein localizes not only to the presynaptic neural terminals
but also to the mitochondria, whose membranes are unique in eukary-
otes because they contain cardiolipin (CL), an anionic phospholipidUniversity of North Carolina at
6 3671; fax: +1 919 843 1580.
l rights reserved.with two phosphatidyl glycerol moieties (Fig. 1B). This localization is
associated with mitochondria dysfunction [12–14] including impair-
ment of complex I [15,16], oxidative stress [17], mitochondrial lipid
abnormalities [16], and mitochondrial ﬁssion [18]. The protein is also
involved in aging, but the reasons for its age-related loss of function
are unknown [11]. Here,we focus on interactionswith themitochondri-
al membrane.
The interaction of α-synuclein with vesicles of different lipid com-
position, phospholipid headgroups, sizes, and surfaces has been stud-
ied [19–30]. The protein has a higher afﬁnity for small unilamellar
vesicles than for large unilamellar vesicles (LUVs), and binds more
strongly to vesicles containing anionic phospholipids [10,19,20,31].
However, little attention has been focused on quantitative assess-
ment of interactions with bilayers that mimic the lipid compositions
of the mitochondrial inner and outer membranes.
We used ﬂuorescence anisotropy and high resolution nuclear
magnetic resonance spectroscopy (NMR) to investigate the interac-
tion of wild-type α-synuclein and one of its familial Parkinson's dis-
ease variants [32], A30P, with LUVs having lipid compositions
similar to the inner and outer mitochondrial membranes. We evaluat-
ed the importance of CL as well as the effect of saturated and unsatu-
rated CL acyl side chains. We also investigated the effect of
temperature, and using 19F-labeled α-synuclein, we determined
which region of the protein interacts with LUVs containing CL. The
results advance our understanding of α-synuclein's interaction with
mitochondrial membranes.
BA
Fig. 1. Schematic representation of α-synuclein (A) showing the four tyrosines (red), the position labeled with dye (green), and the A30P point mutation (blue). (B) Structural
formulas of the CLs used to prepare LUVs. NAC refers to the non amyloid component of α-synuclein.
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2.1. Expression, puriﬁcation, and labeling of human α-synuclein and its
A30P variant
Wild-type α-synuclein, A30P α-synuclein, V3C α-synuclein and
V3C;A30Pα-synucleinwere expressed from a T7-7 plasmid in Escherichia
coli BL21-Gold(DE3) competent cells (Stratagene Cloning Systems, La
Jolla, CA). The proteins were puriﬁed as described [33,34].
The V3C mutation was made by using a Stratagene site-directed
mutagenesis kit. The cysteine was used to attach Alexa Fluor 488
(Invitrogen, Carlsbad, CA). For labeling, 12 mg of V3C α-synuclein
were dissolved in sterile, degassed water to a ﬁnal concentration of
2 mg/mL. Tris(2-carboxyethyl)phosphine and NaHCO3 were added
in a 10-fold molar excess over the protein. The mixture was incubated
at room temperature with shaking for 30 min. Next, Alexa Fluor 488
C5-maleimide was added in a 10-fold molar excess over the protein
and the mixture incubated at room temperature with shaking for2 h. The labeled protein was puriﬁed with gel ﬁltration chromatogra-
phy by using a Superdex 75 column eluted with 20% acetonitrile in
phosphate buffered saline (NaCl 137 mM, KCl 2.7 mM, Na2HPO4
10 mM, KH2PO4 1.8 mM). The labeled protein was dialyzed against
water.
The extinction coefﬁcient of the dye at 494 nm (71,000 M−1 cm−1)
was used to quantify the labeled protein. The Lowry method (Pierce,
Rockford, IL) was used to quantify the total protein. The degree of label-
ingwas 84% for V3Cα-synuclein and 99% for V3C;A30Pα-synuclein. Al-
iquots containing 1 mgof labeled proteinwere lyophilized and stored at
−80 °C.
For NMR experiments, wild-type and Y125F α-synuclein labeled
with 3-ﬂuoro-L-tyrosine were prepared as described [35].
2.2. Cell culture and mitochondria isolation
Human epithelial carcinoma cells (HeLa) from the ATCC were cul-
tured inDulbelcco'smodiﬁed Eagle'smedium(Invitrogen) supplemented
A B 
D C 
Fig. 2. Isolated mitochondrion from HeLa cells incubated with ﬂuorescently-labeled α-
synuclein (A), and Mito Tracker Red (B), differential interference contrast (C), and the
merged images (D).
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The cultureswere incubated at 37 °C in 5% CO2.Mitochondriawere isolat-
ed from HeLa cells (2×107 cells) by using the Mitochondria Isolation Kit
for Cultured Cells from Pierce. Their activity was tested by assessing the
cytochrome c oxidase activity with the Mitochondria Activity Assay Kit
from BioChain Institute, Inc. (Hayward, CA).
2.3. Mitochondrial import of α-synuclein
Freshly isolated mitochondria were incubated with ﬂuorescently-
labeled α-synuclein in the presence of energy mixture and transport
buffer as described [36]. Trypsin was used to remove α-synuclein at-
tached to the surface of mitochondria. Mito Tracker Red CMXRos
(Invitrogen) was used to stain the active mitochondria after protein
import and trypsinization. Fused silica and glass microscope slides
were prepared as described [37]. Mitochondria containing α-
synuclein were allowed to attach to the poly-L-lysine coated slide
for 30 min and then rinsed with minimal media. α-Synuclein import
was assessed by using confocal microscopy on an inverted laser scan-
ning microscope (Zeiss 510 Meta, Thornwood, NY) equipped with a
63×1.4 NA, Plan-Apochromat, oil immersion objective.
2.4. Vesicle preparation and characterization
Lipids were purchased from Avanti Polar Lipids, Inc. (Birmingham,
AL) in chloroform, except cholesterol (CH, from ovine wool), which
was dissolved in chloroform to a concentration of 1 mg/mL and stored
at −20 °C. The lipids were used without further puriﬁcation.
Aliquots of lipids in chloroform,weremixed in glass vials and the sol-
vent was removed overnight in a vacuum concentrator. The dried mix-
tures were suspended in 1 mL of 50 mM sodium phosphate buffer, pH
7.4, to a ﬁnal lipid concentration of 2 mM. The following lipids
were used for preparing LUVs: CH (cholesterol), CL (bovine heart),
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE), 1′,3′-bis[1,2-dimyristoyl-sn-
glycero-3-phospho]-sn-glycerol (TM CL), and 1′,3′-bis[1,2-dioleoyl-sn-
glycero-3-phospho]-sn-glycerol (TO CL). Fig. 1B shows the structures of
CLs.
Vesicles of composition DOPC:DOPE:CL:CH 2.0:1.3:1.0:0.6 molar
ratio and DOPC:DOPE:CH 4.0:2.0:0.9, corresponding to inner and
outer membrane of mitochondria [38], respectively, were prepared.
LUVs with different ratios of CL (1.0, 0.8, 0.5, and 0) or different CL
acid side chains (TM and TO) were also prepared.
LUVs were prepared by multiple extrusion [20,31,39] through a
0.1 μm polycarbonate membrane (Whatman Inc., Sanford, ME).
For NMR experiments, the vesicles were prepared with the same
protocol, but at a concentration of 4 mM. The dried mixture corre-
sponding to the inner mitochondrial membrane was resuspended in
50 mM sodium phosphate buffer, pH 7.4, containing 10% D2O. The
ﬁnal concentration of 19F labeled protein in the NMR tube was
100 μM and the protein:lipid molar ratio was ~1:100. Protein in buff-
er alone was used as a reference.
Vesicles size and its distribution were characterized with dynamic
light scattering (Zetasizer Nano ZS, Malvern Instruments, Southborough,
MA).Measurementswere performed on freshly prepared LUVs and LUVs
stored for 72 h at 4 °C. The LUV concentrationwas 2 mM in 50 mM sodi-
um phosphate buffer, pH 7.4. The measurements were performed at
25 °C with the viscosity and refraction index set to those for water.
2.5. NMR
19F spectra were acquired at 25 °C on a Varian Inova 600 MHz
spectrometer equipped with a 5 mm triple resonance probe. The
spectra comprised 2048 transients with a 30 kHz sweep width. The
chemical shift was referenced to triﬂuoroethanol at 0 ppm. The ex-
periments were conducted in triplicate.2.6. Fluorescence anisotropy of labeled proteins
The experiments were conducted on a FluoroLog®-322 spectro-
ﬂuorometer (HORIBA Jobin Yvon Inc., Edison, NJ) with an excitation
wavelength of 495 nm and an emission wavelength of 519 nm. Four
hundred μL of 100 nM protein solution in 50 mM sodium phosphate
buffer, pH 7.4, were titrated with LUVs at 25 or 37 °C.
Each point is the average of ﬁve measurements, and each condi-
tion was tested in triplicate. Control measurements using only LUVs
or unlabeled wild-type α-synuclein in the same buffer were per-
formed to assess background ﬂuorescence, which was negligible.
The anisotropy was calculated as described [40]. The dissociation
constants (Kd) were calculated by ﬁtting the data to a one site
model (SigmaPlot 11.0).
2.7. DPH ﬂuorescence anisotropy
1,6-Diphenyl-1,3,5-hexatriene (DPH) was incubated with LUVs for
1 h at room temperature either in the presence or absence of protein.
Samples comprised 100 nM protein and 300 μM LUVs in 50 mM phos-
phate buffer, pH 7.4. The ﬁnal molar lipid to DPH ratio was 300:1.
Fluorescence anisotropy was recorded at 25 °C by using an excitation
wavelength of 360 nm and an emission wavelength of 440 nm. Fluo-
rescence anisotropy was also measured at 37 °C for CL inner mem-
brane LUVs in the presence or absence of wild-type or A30P α-
synuclein. The result for each condition is the average of ﬁve
measurements.
3. Results
3.1. In vitro mitochondrial import of α-synuclein
Fluorescently-labeledα-synuclein was localized in isolated mito-
chondria (Fig. 2A). Mito Tracker Red CMXRos is an indicator of active
mitochondria because its accumulation is related to membrane po-
tential. The red ﬂuorescence shows that mitochondria are active
after protein import and trypsinization (Fig. 2B). Co-localization of
ﬂuorescently-labeled protein and Mito Tracker Red indicates that
Fig. 3. Interaction of ﬂuorescently-labeled V3C (A) and V3C;A30P (B) α-synucleins
with LUVs having a composition similar to that of the inner (○) and outer (●) mem-
branes. Error bars represent the standard deviations from triplicate experiments.
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ﬁndings are consistent with those of Devi et al. [13]. To understand
the distribution of α-synuclein in the inner and outer membrane,
we used lipid vesicles with a composition similar to these
membranes.
3.2. Interaction with LUVs having lipid compositions similar to the inner
and outer mitochondrial membrane
Mitochondria contain 25.3% phospholipid by mass [38]. In terms of
composition, the mitochondria comprise 40.8% phosphatidyl choline,
37.4% phosphatidyl ethanolamine, 19.1% CL, and ~3% phosphatidyl
inositol. The major phospholipids of the outer membrane are phos-
phatidyl choline (55.2%), and phosphatidyl ethanolamine (25.3%).
The major phospholipids of the inner membrane are phosphatidyl
choline (44.5%), phosphatidyl ethanolamine (27.7%), and CL (21.5%).
Although the amount of CL in the outer membrane is small, the
exact value remains controversial [41,42]. Nevertheless, there is at
least 40 times more CL in the inner membrane than in the outer
membrane [43].
Fluorescence anisotropy was used to quantify the interaction of
ﬂuorescently-labeled V3C α-synuclein and V3C;A30P α-synuclein
with LUVs. Alexa Fluor 488 dye was chosen because of its high photo-
stability [44]. Labeling at position 3 was selected because this region
is highly dynamic, decreasing the possibility that the modiﬁcation
will disrupt the native conformation [45]. The average diameter of
the LUVs, as determined by dynamic light scattering, is ~140 nm, con-
sistent with values for vesicles extruded through membranes with
100 nm pores [20,31]. The vesicles were stable for at least three
days if kept at 4 °C in 50 mM sodium phosphate buffer, pH 7.4. Never-
theless, the vesicles were used within 48 h. The presence or absence
of CH or CL did not affect vesicle size.
First, we studied the interaction of ﬂuorescently-labeled proteins
with LUVs having a molar DOPC:DOPE:Cholesterol (CH) ratio of
4.0:2.0:0.9, which corresponds to the composition of the outer
membrane. No change in the anisotropy was noted when titrating
100 nM protein with LUVs, suggesting limited afﬁnity of ﬂuores-
cently labeled V3C or V3C;A30P α-synuclein for this type of vesicle
(Fig. 3A and B).
LUVs with a molar ratio corresponding to the inner membrane
(DOPC:DOPE:CL:CH, 2.0:1.3:1.0:0.6) gave strikingly different results
(Fig. 3); both the wild-type protein and the A30P variant bind
with sub mM dissociation constants. As shown in Table 1, V3C α-
synuclein binds slightly more strongly (Kd 130 μM) than the V3C;
A30P variant (Kd 210 μM). Since only the inner membrane contains
CL, these observations implicate CL in the binding of α-synuclein
and are consistent with studies showing that α-synuclein interacts
with vesicles containing anionic phospholipids [10,20,24,46].
3.3. Importance of CL
α-Synuclein is also mostly associated with the inner membrane of
mitochondria in brains from patients with Parkinson's disease
[13,15]. In terms of phospholipids, brains of mice lacking α-
synuclein have reduced levels of only CL and phosphatidylglycerol
(a CL precursor) [16]. Since CL is mitochondria-speciﬁc, we decided
to investigate α-synuclein binding to LUVs containing different
amounts of this phospholipid. The data are shown in Fig. 4, and the
Kd values are compiled in Table 1.
LUVs containing DOPC, DOPE, and CH in molar ratios correspond-
ing to the inner mitochondrial membrane were prepared with 100%,
80%, 50%, and 0% CL, where 100% represents the normal amount in
the inner membrane. For V3C α-synuclein, decreasing the CL by 20%
causes less than a two-fold increase in Kd, but halving the CL increases
Kd by a factor of six. No binding was noted when CL was absent
(Fig. 4A). These ﬁndings show that CL is essential for the interactionbetween α-synuclein and the inner mitochondrial membrane and
that the afﬁnity increases with CL concentration.
We also studied the interaction of the A30P variant with these
LUVs. The decrease in afﬁnity is even stronger for the variant than it
is for the wild-type protein (Fig. 4B, Table 1).3.4. Effect of acyl group
For the studies described above we used bovine heart CL, whose
side chains contain two double bonds, one between C6 and C7, the
other between C9 and C10 (Fig. 1B). In brain CL, however, oleic acid,
which has only the former double bond, is the most abundant fatty
acid [47]. To examine the effect of side chain saturation on α-
synuclein binding, LUVs with a molar ratio corresponding to the
lipid composition of the inner membrane were prepared by using
TOCL, with its four oleic acid chains (Fig. 1B).
The results are shown in Fig. 5, and the Kd values are compiled in
Table 1. The V3C variant binds LUVs with the more abundant side
chain more strongly (Kd 67 μM) than LUVs containing two double
bonds (Kd 130 μM).
The afﬁnity of A30P α-synuclein for LUVs containing one double
bond per side chain (Kd 153 μM) is nearly the same as its afﬁnity for
LUVs with two (Kd 210 μM). We conclude that α-synuclein prefers
the LUVs with compositions that most closely mimic those from
brain mitochondria.
Table 1
Dissociation constants (μM) of ﬂuorescently-labeled α-synucleins.*
OM CL 100% CL 80% CL 50% CL 0% TO CL TM CL CL 100%
(IM) (IM) (IM) (IM) (IM) (IM) (IM) 37 °C
V3C – 130±20 210±20 850±120 – 67±3 3000±4000 59±3
V3C;A30P – 210±20 680±150 1200±700 – 153±7 – 230±20
* Data were acquired at 25 °C unless otherwise speciﬁed; OM, outer membrane; IM, inner membrane; 100%, 80%, 50%, and 0%, LUVs with IM compositions of 100%, 80%, 50% and 0% CL,
respectively; TO CL and TM CL, LUVs of IM lipid composition with saturated CL (TM) or CL possessing one double bound (TO); –, Kd could not be estimated.
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Since V3C α-synuclein and V3C;A30P α-synuclein are labeled
with the dye at a single position (Fig. 1A), the ﬂuorescence anisotropy
studies provide information about protein binding, but not positional
information.
19F NMR was used to test the effect of chain saturation and to de-
termine if the speciﬁc regions of α-synuclein bind differently. 19F is
sensitive to its environment, such that small changes in the structure
of a labeled region are easily detected.Fig. 4. Differential binding afﬁnity of ﬂuorescently labeled-V3C (A) and -V3C;A30P
(B) α-synucleins to LUVs having a composition similar to the innermembrane but varying
amounts of CL. Error bars represent the standard deviations from triplicate experiments.α-Synuclein has four tyrosines, one at position 39 in the N-
terminal region and the others near the C-terminus at positions 125,
133, and 136 (Fig. 1A). The 19F NMR spectrum of 3-ﬂuoro-tyrosine-
labeled wild-type α-synuclein in buffer alone exhibits only three
resonances (Fig. 6A). As shown by Li et al., [35], the middle resonance
is a composite of resonances from tyrosines 39 and 125. We used the
Y125F variant to eliminate the overlap (Fig. 6 B).
Spectra acquired in the presence of vesicles containing CL with
two (CL), one (TO), and no (TM) double bonds are shown in Fig. 6
C, D, and E, respectively. The spectra in panels C, D and E are similar
despite the differences in afﬁnity (Table 1). This is because the high
concentrations required for NMR result in almost complete bindingFig. 5. Binding of ﬂuorescently labeled-V3C (A) and -V3C;A30P (B) α-synucleins to LUVs
with a composition similar with inner membrane but different degrees of side chain
saturation. Error bars represent the standard deviations from triplicate experiments.
133 136
39,125
133
13639
A B C D E
19F Chemical Shift (ppm)
Fig. 6. 19F NMR spectra of tyrosine labeled wild-type (A) and Y125F (B) α-synuclein in buffer and the labeled Y125F variant in the presence of LUVs containing 100% CL (C), TO CL
(D), and TM CL (E). Assignments are shown above the resonances [35]. The molar ratio of protein to lipid is ~1:100.
517I.G. Zigoneanu et al. / Biochimica et Biophysica Acta 1818 (2012) 512–519for all samples despite the difference in Kd values. The fact that the
resonances from positions 133 and 136 are unchanged by the LUVs,
but the resonance from position 39 decreases (Fig. 6C–E), indicates
that N-terminal region of the protein interacts with the vesicles.
3.6. Temperature and binding
Table 1 shows the afﬁnities at 25 °C (Fig. 3A and B) and 37 °C
(Fig. 7) of ﬂuorescently-labeled V3C α-synuclein and V3C;A30P α-
synuclein for LUVs with a composition corresponding to the inner
membrane. The afﬁnity of V3C α-synuclein is two fold greater (Kd
59 μM) at 37 °C than it is at 25 °C (Kd 134 μM), but the afﬁnity of
the V3C;A30P protein is unaffected.
3.7. DPH ﬂuorescence anisotropy
The ﬂuorescence anisotropy of DPH was used to examine the
packing density of LUVs with different CL acyl side chains. The anisot-
ropy depends on the type of phospholipid and its degree of saturation
with higher packing density causing larger anisotropy.
The data (Fig. 8) indicate that in buffer, at 25 °C, LUVs containing
CL with one double bond (TO CL) are as well packed as those contain-
ing two double bonds (CL), but both are better packed than LUVs with
completely saturated cardiolipin (TM CL).Fig. 7. Interaction of ﬂuorescently-labeled-V3C α-synuclein and -V3C;A30P α-
synuclein with LUVs having a composition similar to the inner membrane at 37 °C.
Error bars represent the standard deviations from triplicate experiments.Wild-type and A30P α-synuclein reduce the anisotropy for all
three types of LUVs. The decrease is comparable for wild-type and
A30P α-synucleins. Studies conducted at 37 °C also show a decrease
in anisotropy for CL IM vesicles in the presence of both wild-type
and A30P α-synuclein (Fig. 8, inset). These data show that α-
synuclein perturbs the packing density.
4. Discussion
α-Synuclein interacts with isolatedmitochondria fromHeLa cells and
is imported in the proximity of the inner membrane (Fig. 2). The protein
has no afﬁnity for LUVswith the lipid composition of the outermitochon-
drial membrane (Table 1), which lacks CL. This observation is consistent
with studies showing that α-synuclein enters mitochondria via the pro-
tein import channel [15] rather than through lipid interactions.
A signiﬁcant afﬁnity was noticed for both the wild-type protein
and the A30P variant for LUVs with a composition similar to that of
the inner mitochondrial membrane, with the V3C α-synuclein having
slightly higher afﬁnity (Fig. 3). Vesicles with the lipid composition of
the inner membrane, except that they lack CL, do not bind α-
synuclein. Consistent with this conclusion, decreasing the CL content
reduces α-synuclein afﬁnity (Fig. 4A and B). These observations show
the importance of CL in the inner mitochondrial membrane for α-
synuclein localization.Fig. 8. DPH anisotropy upon the interaction of α-synucleins with LUVs having different
CL acyl side chains at 25 °C. The inset shows the DPH anisotropy in CL IM LUVs in the
presence and absence of α-synucleins at 37 °C. Error bars represent the standard devi-
ations from 5 experiments.
518 I.G. Zigoneanu et al. / Biochimica et Biophysica Acta 1818 (2012) 512–519Our data and those of others show that α-synuclein binds more
tightly to vesicles containing anionic phospholipids such as phospha-
tidylglycerol or phosphatidylserine showing that anionic character is
important for protein binding [10,19,20,30,31]. The fact that the pro-
tein has a higher afﬁnity for smaller vesicles suggests that membrane
curvature [21] or packing also plays a role. Unfortunately, we cannot
tease these apart because cardiolipin is not just negatively charged, it
also affects membrane curvature [17,48], has limited miscibility in bi-
layers [49], and can cause protein clustering [50]. Furthermore,
charge neutralization upon α-synuclein binding also accentuates cur-
vature and causes demixing [29]. In addition, the protein may be
binding membrane defects arising from the poorer packing of vesi-
cles. For these reasons, we cannot distinguish the effects of charge
alone from the effects of charge combined with changes in curvature,
demixing, and packing.
The 19F NMR data suggest that only the N-terminal region inter-
acts with the vesicles. Others have shown that this region interacts
with phospholipid head groups forming an α-helix, while the C-
terminus remains unstructured [20,21,24,25]. The A30P variant has
a lower afﬁnity for anionic lipid vesicles compared to the wild-type
protein (Table 1) as has been reported by others [26,27,30,51].
These observations are consistent with the idea that proline at posi-
tion 30, interrupts the helix in the vesicle bound protein [46].
The increased afﬁnity at higher temperature observed for the
wild-type protein indicates that binding is endothermic, which
means the interaction of the protein with membranes is entropically
favorable. This observation together with the NMR data lead to the
suggestion that the nonpolar strip in the amphipathic N-terminal
helix region of the protein [25] adds to the protein's afﬁnity for vesi-
cles via hydrophobic interactions. However, the temperature depen-
dence could also be brought about by demixing (i.e., differential
enrichment of lipids).
In summary, α-synuclein and the A30P variant have a signiﬁcant
afﬁnity for lipid vesicles with the composition of the innermitochondrial
membrane, but they do not interact with the vesicles mimicking the
outer membrane. The interaction with vesicles mimicking the inner
membrane probably involves electrostatic interactions between the
cationic lysines in the consensus repeat KTKEGV and the anionic
cardiolipin.
The increased afﬁnity of α-synuclein for LUVs made from phos-
pholipids with unsaturated side chains was conﬁrmed [16]. However,
in our study α-synuclein binds more strongly to the TO CL, which
contains one double bond per acyl side chain compared to the CL,
which contains two. This observation is interesting in light of the
fact that most of the CL in brain mitochondria possesses one saturated
and one unsaturated side chain [47], and is consistent with a role for
CL-α-synuclein interactions in Parkinson's disease.
To better understand the afﬁnity of α-synucleins for CL vesicles
containing different fatty acids we investigated the vesicle packing
density by using DPH ﬂuorescence anisotropy. The ﬂuorescence
anisotropy of DPH embedded in a LUV provides information about
membrane ﬂuidity, and hence the packing density of its acyl side
chains. High packing density lowers ﬂuidity, increasing DPH anisotro-
py [52].
The DPH anisotropy decreases when wild-type or A30P α-
synucleins were added to LUVs containing CL with one, two, or no
double bonds, and the percent decrease is similar in both instances
(Fig. 8). Speciﬁcally, a 16% decrease was noted for TO CL in the pres-
ence of wild-type α-synuclein while an 11% decrease was noted for
TM CL. Also, given the dissociation constants (Table 1), more protein
interacts with TO CL LUVs than with TM CL LUVs. From these observa-
tions we suggest that the binding of α-synuclein to TO CL vesicles in-
duces demixing of CL, causing defects at the membrane-water
interface (unsaturated acyl chains are more dynamic than saturated
chains [53]). We also suggest that the higher afﬁnity of α-synuclein
for TO CL arises from the formation of an amphipathic α-helix, withthe nonpolar residues interacting with nonpolar lipids in the defects,
as has been observed [28].
The DPH anisotropy decreases when wild-type or A30P α-
synucleins were added to LUVs containing CL with one, two, or no
double bonds (Fig. 8). The trend in DPH ﬂuorescence anisotropies fol-
lows the trend in binding constants (Table 1) indicating that stronger
binding leads to decreased DPH anisotropy. We suggest that this
trend follows from the geometry of CL, which has two small head
groups and four acyl chains. The combination of the small head
groups and the large volume of the chains forces the molecule into
a cone-shaped structure [54]. This arrangement enhances structural
rigidity [53], allowing other molecules in the membranes to penetrate
the bilayer. For TM CL, we conjecture that its saturated chains interact
with the acyl side chains from the other lipids and the cholesterol to
maintain the membrane in a more solvent exposed structure, while
for TO CL and IM CL, the unsaturated acyl chains are more dynamic
and able to adjust to a more compact, better packed structure upon
mixing with other components.
Increasing the temperature increases the ﬂuidity of the vesicles,
reducing their packing density. Binding of wild-type protein is stronger
at 37 °C than it is at 25 °C. The stronger binding at higher temperature is
consistent with our conclusion about membrane destabilization by α-
synuclein binding. However, as discussed above, the temperature
dependence is also consistent with the idea that hydrophobic interac-
tions play an important role in binding.
To our knowledge, this is the ﬁrst study to investigate the afﬁnity
of α-synuclein for lipid vesicles with a composition similar to mito-
chondrial membranes. The data explain why α-synuclein has a high
afﬁnity for the inner membrane (it contains CL), show that the inter-
action involves the N-terminal region of the protein, and suggest that
the protein destabilizes the inner membrane. An interesting and po-
tentially biologically important caveat to more detailed interpretation
of our data arises from results showing the limited miscibility of CL in
bilayers [49]. Speciﬁcally, we cannot know whether the interactions
involve the entire vesicle surface or distinct CL-rich domains — i.e.,
so-called lipid rafts [55].
The combination of techniques used here, can also be applied to
monitor the binding of α-synuclein to isolated mitochondria and
mitoplasts. Such investigations should help elucidate the role of α-
synuclein in the mitochondria dysfunction associated with neurode-
generative diseases.Abbreviations
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